NO306714B1 - Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosin - Google Patents
Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosinInfo
- Publication number
- NO306714B1 NO306714B1 NO962294A NO962294A NO306714B1 NO 306714 B1 NO306714 B1 NO 306714B1 NO 962294 A NO962294 A NO 962294A NO 962294 A NO962294 A NO 962294A NO 306714 B1 NO306714 B1 NO 306714B1
- Authority
- NO
- Norway
- Prior art keywords
- polymorphic form
- crystalline
- mesyllysylamino
- cyclopentylcarbonyl
- tyrosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939324931A GB9324931D0 (en) | 1993-12-04 | 1993-12-04 | Glutaramide derivatives |
PCT/EP1994/003750 WO1995015308A1 (en) | 1993-12-04 | 1994-11-09 | Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
Publications (3)
Publication Number | Publication Date |
---|---|
NO962294L NO962294L (no) | 1996-06-04 |
NO962294D0 NO962294D0 (no) | 1996-06-04 |
NO306714B1 true NO306714B1 (no) | 1999-12-13 |
Family
ID=10746163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO962294A NO306714B1 (no) | 1993-12-04 | 1996-06-04 | Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosin |
Country Status (26)
Country | Link |
---|---|
US (1) | US6180665B1 (no) |
EP (1) | EP0731787B1 (no) |
JP (1) | JP2701988B2 (no) |
KR (1) | KR100203314B1 (no) |
CN (1) | CN1068586C (no) |
AT (1) | ATE175664T1 (no) |
CA (1) | CA2178085C (no) |
CZ (1) | CZ296428B6 (no) |
DE (1) | DE69416003T2 (no) |
DK (1) | DK0731787T3 (no) |
EG (1) | EG20562A (no) |
ES (1) | ES2128031T3 (no) |
FI (1) | FI120305B (no) |
GB (1) | GB9324931D0 (no) |
GR (1) | GR3029590T3 (no) |
HU (1) | HU225959B1 (no) |
IL (1) | IL111791A (no) |
MY (1) | MY115430A (no) |
NO (1) | NO306714B1 (no) |
NZ (1) | NZ276087A (no) |
PE (1) | PE9296A1 (no) |
PL (1) | PL178559B1 (no) |
RU (1) | RU2131869C1 (no) |
TW (2) | TW534901B (no) |
WO (1) | WO1995015308A1 (no) |
ZA (1) | ZA949595B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2420043A1 (en) | 2000-08-29 | 2002-03-07 | Riverside Forest Products Limited | Collapsible bin |
FR2824477B1 (fr) * | 2001-05-09 | 2005-09-09 | Ethypharm Lab Prod Ethiques | Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes |
US6975515B2 (en) | 2001-08-15 | 2005-12-13 | Agilent Technologies, Inc. | Electrical module |
CN101219992B (zh) * | 2003-02-12 | 2011-08-31 | 日产化学工业株式会社 | 匹伐他汀钙的晶形 |
WO2005123702A1 (en) * | 2004-06-15 | 2005-12-29 | Pfizer Limited | Neutral endopeptidase inhibitor polymorph |
CN109350736A (zh) * | 2018-09-20 | 2019-02-19 | 南通大学 | 防治运动病、梅尼埃病的药物及心房钠尿肽的医药用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
US5208236A (en) * | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
-
1993
- 1993-12-04 GB GB939324931A patent/GB9324931D0/en active Pending
-
1994
- 1994-11-07 TW TW089110999A patent/TW534901B/zh not_active IP Right Cessation
- 1994-11-07 TW TW083110283A patent/TW434210B/zh not_active IP Right Cessation
- 1994-11-09 CA CA002178085A patent/CA2178085C/en not_active Expired - Fee Related
- 1994-11-09 US US08/648,001 patent/US6180665B1/en not_active Expired - Fee Related
- 1994-11-09 DE DE69416003T patent/DE69416003T2/de not_active Expired - Lifetime
- 1994-11-09 EP EP95900719A patent/EP0731787B1/en not_active Expired - Lifetime
- 1994-11-09 ES ES95900719T patent/ES2128031T3/es not_active Expired - Lifetime
- 1994-11-09 WO PCT/EP1994/003750 patent/WO1995015308A1/en active IP Right Grant
- 1994-11-09 RU RU96115251A patent/RU2131869C1/ru not_active IP Right Cessation
- 1994-11-09 CZ CZ0160496A patent/CZ296428B6/cs not_active IP Right Cessation
- 1994-11-09 KR KR1019960702912A patent/KR100203314B1/ko not_active IP Right Cessation
- 1994-11-09 HU HU9601506A patent/HU225959B1/hu not_active IP Right Cessation
- 1994-11-09 AT AT95900719T patent/ATE175664T1/de not_active IP Right Cessation
- 1994-11-09 CN CN94194942A patent/CN1068586C/zh not_active Expired - Fee Related
- 1994-11-09 DK DK95900719T patent/DK0731787T3/da active
- 1994-11-09 PL PL94314794A patent/PL178559B1/pl not_active IP Right Cessation
- 1994-11-09 NZ NZ276087A patent/NZ276087A/en not_active IP Right Cessation
- 1994-11-09 JP JP7515356A patent/JP2701988B2/ja not_active Expired - Fee Related
- 1994-11-28 PE PE1994255868A patent/PE9296A1/es not_active Application Discontinuation
- 1994-11-28 IL IL11179194A patent/IL111791A/en not_active IP Right Cessation
- 1994-11-29 MY MYPI94003169A patent/MY115430A/en unknown
- 1994-12-01 EG EG75294A patent/EG20562A/xx active
- 1994-12-02 ZA ZA949595A patent/ZA949595B/xx unknown
-
1996
- 1996-06-03 FI FI962322A patent/FI120305B/fi not_active IP Right Cessation
- 1996-06-04 NO NO962294A patent/NO306714B1/no not_active IP Right Cessation
-
1999
- 1999-03-05 GR GR990400677T patent/GR3029590T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU34896A (sh) | Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije | |
FI932229A0 (fi) | Azabicykliska bryggderivat | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
DE69729583D1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren | |
DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
CA2318349A1 (en) | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | |
EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
NZ279397A (en) | Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions | |
EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
MX9306425A (es) | Compuestos benzoheterociclicos, procedimiento parasu preparacion y composiciones antagonistas de la vasopresina y la oxitocina, que contienen dichos compuestos. | |
NO941958L (no) | Fremstilling av substituerte piperidiner | |
NZ331875A (en) | Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs | |
NO962294D0 (no) | Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propylÅ-1-cyklopentylkarbonyl)-tyrosin | |
FI963168A (fi) | Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia | |
GB9806409D0 (en) | Processes for preparing intermediates | |
DE69827614D1 (de) | Chinoxalindionen | |
CA2171972A1 (en) | Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |